Understanding adverse events of immunotherapy: A mechanistic perspective

The treatment of many cancers has been revolutionized by immune checkpoint blockade (ICB) as a standard-of-care therapeutic. Despite many successes, a large proportion of patients treated with ICB agents experience immune-related adverse events (irAEs) in the form of clinical autoimmunity, ranging f...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Kelly P., Grebinoski, Stephanie, Sharpe, Arlene H., Vignali, Dario A.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754677/
https://www.ncbi.nlm.nih.gov/pubmed/33601411
http://dx.doi.org/10.1084/jem.20192179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754677/
https://www.ncbi.nlm.nih.gov/pubmed/33601411
http://dx.doi.org/10.1084/jem.20192179

Ejemplares similares